Devers Shannon L.
Devers Shannon L., EVP, CHRO, reported an open-market or private sale at IONIS PHARMACEUTICALS INC involving 1357.000000 shares for an estimated $59081.88. Reported holdings after the transaction were 17811.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 16, 2026
- Filing date
- Oct 20, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 19,168 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
IONS price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0000874015-26-000267 Common Stock
- Transaction date
- Oct 16, 2026 Filed Oct 20, 2026, 01:40 AM · 4d delay
- Shares
- 1,357 sh $43.54 per share
- Estimated value
- -$59.0k Computed from shares × price
- Holdings after
- 17,811 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
EVP, Chief Human Resources Ofc
- F1
Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award.
- F2
The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.1383 to $43.538918 inclusive. The reporting person undertakes to…
- F4
Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- F5
Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Compa…
0 other transactions
0 recent txs